Compare tool
BPC-157 vs TB-500 (Thymosin Beta-4)
Same attributes, same format, up to four peptides. Then let the advisor explain the trade-offs in plain language.
Peptide C
Educational only, not medical advice.
| Attribute | BPC-157 Bone, Joint & Connective Tissue | TB-500 (Thymosin Beta-4) Cardiovascular & Pulmonary Health |
|---|---|---|
| Route | Subcutaneous / Oral Research | Subcutaneous |
| Dose range | 250 mcg – 1 mg | 500 mcg – 1 mg |
| Frequency | Once or twice daily (subcutaneous). | Once per day (subcutaneous). |
| Timing | Consistent daily schedule; rotate injection sites. | Any consistent time daily; rotate injection sites. |
| Cycle length | 8–12 weeks. | 8–12 weeks. |
| Vial options | 5 mg, 10 mg | 5 mg, 10 mg |
| Studied benefits | Accelerates healing in gut, tendon, muscle, and skin; possesses strong anti-inflammatory and cytoprotective properties. | Promotes rapid wound healing, tissue repair, and the growth of new blood vessels (angiogenesis). It is widely used in research and veterinary settings to reduce inflammation and prevent excessive scar tissue (fibrosis) after injury. |
| Reported side effects | Good tolerability in early trials; side effects are primarily limited to mild injection-site redness or itching. | Generally well-tolerated; human data is limited, but research settings report only occasional mild redness or tenderness at the injection site. |
| Cited studies | 9 | 7 |
| N1 Aminos | from $39.00 → Code DOSING15 · 15% off first order | from $59.00 → Code DOSING15 · 15% off first order |
| Calculator | Do the math | Do the math |
AI explanation
Click “Explain the trade-offs” for a plain-language read on mechanism, dosing scale, side-effect profile and research depth.
BPC-157 vs TB-500 (Thymosin Beta-4)